SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about board meeting

03 Jun 2016 Evaluate

Medicamen Biotech has informed that a meeting of the Board of Directors of the Company will be held on June 10, 2016, to consider the Preferential Allotment of Equity Shares & Convertible Warrants into Equity Shares.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

256.40 -0.70 (-0.27%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×